Acclinate
United States
- Birmingham, AL
- 08/05/2024
- Series A
- $17,000,000
Our vision is health equity through inclusive research. We help pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.
- Industry Biotechnology
- Website https://www.acclinate.com/
- LinkedIn https://www.linkedin.com/company/acclinateinc/
Related People
Del Smith, PhDFounder
United States -
Birmingham, Alabama
Dr. Del Smith uses his diverse background in healthcare, IT, higher education, and business to drive greater healthcare equity. He is the CEO and Cofounder of Acclinate, a company using sustained community engagement and AI to mobilize historically marginalized communities for greater equity in healthcare.
Prior to cofounding Acclinate, Del dedicated nearly fifteen years to higher education as a business professor and then Dean of a business school. His research on success factors of minority-owned businesses has been published in journals such as the Journal of Business Research and the Journal of Developmental Entrepreneurship.
Del is a U.S. Army veteran and holds a Ph.D. in Business from the University of Alabama.
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)